Rocket


News + Filings
Transactions



Thompson Peter A.

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/27/2023ARS Pharmaceuticals, Inc.SBTXGrantStock Option (right to buy)40k$6.50$260k 06/27/2023
01/03/2023ALPINE IMMUNE SCIENCES, INC.NVLSGrantStock Option (Right to buy)10k$0.00$0 01/03/2023
09/16/2022Edgewise Therapeutics, Inc. PurchaseCommon Stock484.5k$10.32$5MSee Footnotes09/16/2022
08/11/2022Corvus Pharmaceuticals, Inc.CRVSGrantStock Option (Right to Buy)15k$0.97$14.5k 08/11/2022
06/24/2022Edgewise Therapeutics, Inc. GrantStock Option (Right to Buy)42.1k$8.53$359k 06/24/2022
06/17/2022Decibel Therapeutics, Inc.DBTXGrantStock Option (right to buy)10k$2.30$23k 06/17/2022
06/15/2022Corvus Pharmaceuticals, Inc.CRVSGrantStock Option (Right to Buy)15k$0.99$14.8k 06/15/2022
06/14/2022Janux Therapeutics, Inc. GrantStock Option (right to buy)12.5k$10.73$134.1k 06/14/2022
06/10/2022ARS Pharmaceuticals, Inc.SBTXGrantStock Option (right to buy)18k$4.18$75.2k 06/10/2022
06/02/2022PMV Pharmaceuticals, Inc.PMVPGrantStock option (right to buy)16.3k$32.29$527.4k 06/02/2021
05/18/2022Edgewise Therapeutics, Inc. PurchaseCommon Stock138k$7.21$995kSee Footnotes05/18/2022
01/03/2022ALPINE IMMUNE SCIENCES, INC.NVLSGrantStock Option (Right to buy)10k$0.00$0 01/03/2022
12/29/2021Janux Therapeutics, Inc. SaleCommon Stock36.7k$20.30$745kSee Footnotes12/29/2021
12/29/2021Janux Therapeutics, Inc. SaleCommon Stock3.7k$20.30$75.1kSee Footnotes12/29/2021
12/21/2021Janux Therapeutics, Inc. SaleCommon Stock11.1k$19.00$210.9kSee Footnotes12/21/2021
12/21/2021Janux Therapeutics, Inc. SaleCommon Stock108.3k$19.00$2.1MSee Footnotes12/21/2021
12/16/2021Janux Therapeutics, Inc. SaleCommon Stock356.8k$19.07$6.8MSee Footnotes12/16/2021
12/16/2021Janux Therapeutics, Inc. SaleCommon Stock36.5k$19.07$696.1kSee Footnotes12/16/2021
09/20/2021Corvus Pharmaceuticals, Inc.CRVSSaleCommon Stock, $0.0001 par value1.1M$6.09$6.8MSee Footnotes09/20/2021
09/17/2021ALPINE IMMUNE SCIENCES, INC.NVLSPurchaseCommon Stock585.1k$9.40$5.5MSee Footnotes09/17/2021
09/17/2021ALPINE IMMUNE SCIENCES, INC.NVLSPurchaseCommon Stock425.5k$9.40$4MSee Footnotes09/17/2021
09/09/2021Corvus Pharmaceuticals, Inc.CRVSGrantStock Option (Right to Buy)15k$2.60$39k 09/09/2021
06/15/2021Corvus Pharmaceuticals, Inc.CRVSGrantStock Option (Right to Buy)15k$2.74$41.1k 06/15/2021
06/15/2021Janux Therapeutics, Inc. ConversionCommon Stock1.3M$0.00$0See footnotes06/15/2021
06/15/2021Janux Therapeutics, Inc. ConversionCommon Stock823.7k$0.00$0See footnotes06/15/2021
06/15/2021Janux Therapeutics, Inc. PurchaseCommon Stock588.2k$17.00$10MSee footnotes06/15/2021
06/15/2021Janux Therapeutics, Inc. ConversionCommon Stock164.7k$0.00$0See footnotes06/15/2021
06/15/2021Janux Therapeutics, Inc. PurchaseCommon Stock117.6k$17.00$2MSee footnotes06/15/2021
06/15/2021Janux Therapeutics, Inc. ConversionSeries A Convertible Preferred Stock1.1M$0.00$0See footnotes06/15/2021
06/15/2021Janux Therapeutics, Inc. ConversionSeries B Convertible Preferred Stock643k$0.00$0See footnotes06/15/2021
06/15/2021Janux Therapeutics, Inc. ConversionSeries B Convertible Preferred Stock128.6k$0.00$0See footnotes06/15/2021
06/10/2021Janux Therapeutics, Inc. GrantStock Option (right to buy)30k$17.00$510k 06/10/2021
06/04/2021ARS Pharmaceuticals, Inc.SBTXGrantStock Option (right to buy)15k$28.83$432.4k 06/04/2021
03/30/2021Edgewise Therapeutics, Inc. ConversionSeries B-1 Preferred Stock1.6M$0.00$0See Footnotes03/30/2021
03/30/2021Edgewise Therapeutics, Inc. ConversionSeries A Preferred Stock8.2M$0.00$0See Footnotes03/30/2021
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy